Altasciences is delighted to announce the addition of Dr Lynne LeSauteur, PhD, to their bioanalytical management team, who will be responsible for the Bioanalytical Services department in the USA, as well as the Ligand Binding team in Canada.

Lynne has a PhD in Pharmacology and Therapeutics from McGill University and has over 20 years’ experience in biologic drug development.

Most recently, she was Director of Downstream Processing and Analytics, as well as Program Leader Biologics and Biomanufacturing for the Human Health Therapeutics Research Center at the National Research Council of Canada (NRC) where Lynne led numerous teams and initiatives to discover, biomanufacture and characterise novel biologics for unmet needs, in collaboration with different biopharmaceutical companies.

Prior to the NRC, Lynne worked at Charles River Laboratories where she established the Immunology Department, and led the scientific and strategic growth of that group from one to over 80 employees, effectively delivering expertise to sponsors to progress numerous biologics through the drug development value chain.

“We are extremely pleased to welcome Lynne to the team at Altasciences. The breadth of her experience in both preclinical and clinical drug development, including her in-depth knowledge of immunotoxicology, immunogenicity, immunoassays, molecular biology, and biomarkers, will continue to enhance scientific guidance to our growing base of small- to mid-size clients,” said Marie-Hélène Raigneau, Executive Vice President, Research Services, at Altasciences.

Altasciences’ bioanalytical team consists of more than 100 dedicated scientists in both the USA and Canada who provide a comprehensive suite of bioanalytical services, from discovery to preclinical to phase IV clinical support, for both small and large molecules including immunogenicity, biomarker and PK.

For more information, please fill out the enquiry form attached to this page.